PTPRC and neoplasm: Consistent with conventional knockout data, specific deletion of Gpr54 in T cells significantly impaired LLC tumor growth (Figure 5A) and markedly increased intratumoral CD45+ cells (Figure 5B) and CD8+ T cells (Figure 5C).